Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Cinnal-F 900IU


Contraindicated

Contraindicated
Cinnal-F 900IU :
Type Medicine Authorised
Note Medicine registered upon Minister decision
Originator Gonal-F 900IU Pen
Agent Lebiran
Distributor Lebiran
Laboratory CinnaGen
Responsible Party Cinnagen Co
Origin Iran
Manufacturer CinnaGen Co
Manufacturing Type G
Origin Iran
ATC G03GA05

Your comment will appear shortly after approval

Cinnal-F 900IU :

Revision Date : 27/07/2010


Effect Frequency
Abdominal discomfort Common
Abdominal distension Common
Abdominal pain Common
Acne Common
Anaphylactic reactions Very rare
Anaphylactic shock Very rare
Asthma Very rare
Diarrhoea (Diarrhea) Common
Embolism Very rare
Gynecomastia (Gynaecomastia) Common
Headache Very Common
Hypersensitivity Very rare
Injection site erythema Very Common
Injection site haematoma Very Common
Injection site irritation Very Common
Injection site pain Very Common
Injection site reaction Very Common
Injection site swelling Very Common
Nausea Common
Ovarian cyst Very Common
Ovarian hyperstimulation syndrome Common
Varicocele Common
Vomiting Common
Weight increased (weight gain) Common

Different Units By MoH Code

Cinnal-F 900IU  MoH 10086 :
Form Solution for injection
Packaging Pre-filled pen
Package Size 1x1.5ml + diluent
Strength 900IU/1.5ml (66µg/1.5ml)
Public Price 14826544.01 L.L.
Stratum D
NSSF ✘
Quarantine ✘
Reg. Number 139219/1
Submission date 18/09/2019
Registration Year 07/11/2019
Pending Year 25/09/2019
Pending Reason Incomplete file


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x1.5ml + diluent
● Public Price: 14826544.01 LBP ( 14,826,544.01 LBP )
● Pack size unit used: 900
● Cost/Unit: 16473,94 LBP ( 16,473.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info